Linear root water uptake by vegetation

The performance of a simple model with a linear root water extraction term that varies with time is presented in this paper. The research is based on the use of a one-dimensional form of Richard’s Equation for unsaturated moisture flow including a sink term. A numerical solution has been achieved via the finite element method for spatial discretisation along with a finite difference time-marching scheme. The model is assessed via a series of simulations of water uptake beneath uniform crop cover. A good correlation between the field data and simulated results has been achieved. This relatively straight forward approach is seemed more suitable for development and application to a range of geoengineering problems such as slope stability, shrinkage and heave prediction

Ictal kissing: occurrence and etiology.

Ictal kissing is a rare semiological manifestation in patients with epilepsy. We tried to estimate its occurrence and characterize the underlying etiology. We retrospectively reviewed all video-EEG reports from Jefferson Comprehensive Epilepsy Center over a 12-year period (2004-2015) for the occurrence of the term kiss . We then searched the electronic database PubMed on September 21, 2016 using the following search terms in the English language: ictal OR seizure OR epilepsy AND kiss OR kissing . Relevant original studies were included. During the study period, 5133 patients were investigated in our epilepsy monitoring unit. One patient (0.02%) had one episode of documented ictal kissing. He had drug-resistant right mesial temporal lobe epilepsy. In total, five studies met the criteria for inclusion in the review. These studies described nine patients with drug-resistant focal epilepsy and ictal kissing behavior. Six out of ten patients with ictal kissing had hippocampal sclerosis. We add to the literature on ictal kissing by providing additional information on its frequency and etiology. The most common underlying etiology for ictal kissing is hippocampal sclerosis. However, this semiological ictal phenomenon is not pathognomonic for any etiology or localization

Herschel-PACS imaging of protostars in the HH 1–2 outflow complex

We present 70 and 160 μm Herschel science demonstration images of a field in the Orion A molecular cloud that contains the prototypical Herbig-Haro objects HH 1 and 2, obtained with the Photodetector Array Camera and Spectrometer (PACS). These observations demonstrate Herschel’s unprecedented ability to study the rich population of protostars in the Orion molecular clouds at the wavelengths where they emit most of their luminosity. The four protostars previously identified by Spitzer 3.6–40 μm imaging and spectroscopy are detected in the 70 μm band, and three are clearly detected at 160 μm. We measure photometry of the protostars in the PACS bands and assemble their spectral energy distributions (SEDs) from 1 to 870 μm with these data, Spitzer spectra and photometry, 2MASS data, and APEX sub-mm data. The SEDs are fit to models generated with radiative transfer codes. From these fits we can constrain the fundamental properties of the protostars. We find luminosities in the range 12–84 L_⊙ and envelope densities spanning over two orders of magnitude. This implies that the four protostars have a wide range of envelope infall rates and evolutionary states: two have dense, infalling envelopes, while the other two have only residual envelopes. We also show the highly irregular and filamentary structure of the cold dust and gas surrounding the protostars as traced at 160 μm

A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma.

Hepatocellular carcinoma (HCC), the second leading cause of cancer deaths worldwide, is difficult to treat and highly lethal. Since HCC is predominantly diagnosed in patients with cirrhosis, treatment planning must consider both the severity of liver disease and tumor burden. To minimize the impact to the patient while treating the tumor, techniques have been developed to target HCC. Anatomical targeting by surgical resection or locoregional therapies is generally reserved for patients with preserved liver function and minimal to moderate tumor burden. Patients with decompensated cirrhosis and small tumors are optimal candidates for liver transplantation, which offers the best chance of long-term survival. Yet, only 20%-30% of patients have disease amenable to anatomical targeting. For the majority of patients with advanced HCC, chemotherapy is used to target the tumor biology. Despite these treatment options, the five-year survival of patients in the United States with HCC is only 16%. In this review we provide a comprehensive overview of current approaches to target HCC. We also discuss emerging diagnostic and prognostic biomarkers, novel therapeutic targets identified by recent genomic profiling studies, and potential applications of immunotherapy in the treatment of HCC